Skip to main content
. 2024 Dec 21;14:153. doi: 10.1186/s13578-024-01333-2

Fig. 4.

Fig. 4

UHRF1 underlies SIRT6-deficiency-mediated BLCA progression. A Differential analysis of UHRF1 levels in normal and tumor samples from TCGA-BLCA cohort. B 253J cells were transfected with shUHRF1#1 and shScramble, and expressions of UHRF1 were detected with western blotting and RT-qPCR assays. C CCK-8 assay showed that cell viability was decreased in 253J and HT-1376 cells. D-E CCK-8 assay and colony formation assay revealed that cell viability was decreased in SIRT6-KD T24 and UMUC-3 cells after UHRF1 knockdown. F Indicated UMUC-3 cells were subcutaneously injected into BALB/c nude mice. Immunohistochemical detection of Ki-67 and CD34 in tumors derived from indicated cells were shown. G-H Quantification of tumor growth curve and tumor weights were compared among indicated tumors. *p < 0.05, **p < 0.01, ***p < 0.001, ns no significance